Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.

Goineau A, Campion L, d'Aillières B, Vié B, Ghesquière A, Béra G, Jaffres D, de Laroche G, Magné N, Artignan X, Chamois J, Bergerot P, Martin E, Créhange G, Deniaud-Alexandre E, Buthaud X, Belkacémi Y, Doré M, de Decker L, Supiot S.

PLoS One. 2018 Apr 9;13(4):e0194173. doi: 10.1371/journal.pone.0194173. eCollection 2018.

2.

The Role of Circulating Tumor DNA in Renal Cell Carcinoma.

Bergerot PG, Hahn AW, Bergerot CD, Jones J, Pal SK.

Curr Treat Options Oncol. 2018 Feb 20;19(2):10. doi: 10.1007/s11864-018-0530-4. Review.

PMID:
29464405
3.

Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.

Bergerot PG, Bergerot CD, Dizman N, Zequi S, Fay A, Dara Y, Maia MC, Cotta BN, Gonçalves EP, Formiga MN, Tariki MS, Clavijo DA, Choueiri TK, Lopes G, Pal SK.

J Glob Oncol. 2017 Dec 27:JGO1700113. doi: 10.1200/JGO.17.00113. [Epub ahead of print]

PMID:
29281478
4.

Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review.

Maia MC, Adashek J, Bergerot P, Almeida L, Dos Santos SF, Pal SK.

J Geriatr Oncol. 2017 Dec 15. pii: S1879-4068(17)30250-3. doi: 10.1016/j.jgo.2017.11.011. [Epub ahead of print] Review.

PMID:
29249644
5.

Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree.

Bergerot P, Agarwal N, Pal SK, Jones J.

Clin Cancer Res. 2017 Nov 1;23(21):6381-6383. doi: 10.1158/1078-0432.CCR-17-2039. Epub 2017 Sep 14.

PMID:
28912138
6.

Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile.

Dizman N, Bergerot P, Bergerot C, Lanman RB, Raymond VM, Banks KC, Jones J, Pal SK.

Eur Urol. 2018 Feb;73(2):308-310. doi: 10.1016/j.eururo.2017.08.006. Epub 2017 Aug 24. No abstract available.

PMID:
28844598
7.

Case Discussion: Systemic Therapy for Metastatic Renal Cell Carcinoma.

Maia MC, Bergerot P, Pal SK.

Eur Urol Focus. 2016 Dec 15;2(6):579-581. doi: 10.1016/j.euf.2017.02.008. Epub 2017 Mar 1.

PMID:
28723488
8.

Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers' Training in Brazil.

Bergerot CD, Philip EJ, Bergerot PG, Elias S, Guimarães DP, Forones NM, Baiocchi OCCG, Batista NA, De Domenico EBL.

J Glob Oncol. 2016 Sep 21;3(3):189-193. doi: 10.1200/JGO.2016.006148. eCollection 2017 Jun.

9.

Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma.

Pal SK, Karam JA, Bergerot P, Agarwal N.

J Clin Oncol. 2016 Nov 10;34(32):3825-3826. doi: 10.1200/JCO.2016.69.3572. No abstract available.

PMID:
27601540
10.

Renal cell carcinoma: An update for the practicing urologist.

Pal SK, Bergerot P, Figlin RA.

Asian J Urol. 2015 Jan;2(1):19-25. doi: 10.1016/j.ajur.2015.04.012. Epub 2015 Apr 16. Review.

11.

Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

Pal SK, Hsu J, Hsu S, Hu J, Bergerot P, Carmichael C, Saikia J, Liu X, Lau C, Twardowski P, Figlin RA, Yuh BF.

J Geriatr Oncol. 2013 Apr;4(2):128-33.

12.

Preoperative therapy for localized prostate cancer: a comprehensive overview.

Hu J, Hsu J, Bergerot PG, Yuh BE, Stein CA, Pal SK.

Maturitas. 2013 Jan;74(1):3-9. doi: 10.1016/j.maturitas.2012.10.012. Epub 2012 Nov 14. Review.

13.

Tivozanib: current status and future directions in the treatment of solid tumors.

Pal SK, Bergerot PG, Figlin RA.

Expert Opin Investig Drugs. 2012 Dec;21(12):1851-9. doi: 10.1517/13543784.2012.733695. Epub 2012 Sep 26. Review.

14.

Transverse sinus thrombosis associated with otitis media and mastoiditis.

Santos VM, Oliveira ER, Barcelos MS, Figueiredo NC, Santos FH, Bergerot PG.

J Coll Physicians Surg Pak. 2012 Jul;22(7):470-2. doi: 07.2012/JCPSP.470472.

PMID:
22747873
15.

[Ten years of reflection around the announcement of cancer: from the patients questions to implementation].

Bergerot P, Rodde-Dunet MH.

Bull Cancer. 2010 Oct;97(10):1195-6. French. No abstract available.

16.

Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC).

Bourhis J, Calais G, Lapeyre M, Tortochaux J, Alfonsi M, Sire C, Bardet E, Rives M, Bergerot P, Rhein B, Desprez B; French Head and Neck Cancer Group (GORTEC).

Semin Oncol. 2004 Dec;31(6):822-6. Review.

PMID:
15599861
17.

[Refining the French system of cost assessment for oncology patients following chemotherapy].

Lévy-Piedbois C, Borella L, Bergerot P, Peuvrel P, Erard C, Parmentier G, Ravaud A, Trombert Paviot B, Armand JP, Rodrigues JM.

Bull Cancer. 2003 Nov;90(11):989-96. French.

18.

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.

Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G.

J Clin Oncol. 2004 Jan 1;22(1):69-76. Epub 2003 Dec 2.

PMID:
14657228
19.

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.

Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Calais G.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):93-8.

PMID:
12504040
20.

[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].

Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P.

Bull Cancer. 2000 Aug;87 Spec No:48-53. French.

PMID:
11082723
21.

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P.

J Natl Cancer Inst. 1999 Dec 15;91(24):2081-6.

PMID:
10601378
22.

Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas.

Beauvillain C, Mahé M, Bourdin S, Peuvrel P, Bergerot P, Rivière A, Vignoud J, Deraucourt D, Wesoluch M.

Laryngoscope. 1997 May;107(5):648-53.

PMID:
9149168

Supplemental Content

Loading ...
Support Center